Bayes Group
← All Insights
·9 min read

The Differentiation Crisis: Why Every Multi-Strategy Platform Sounds the Same to Allocators

Half of institutional allocators now cite crowding as their top concern with multi-strategy funds. Correlation to equities is at its highest since 2011. Fee structures are under unprecedented scrutiny. For heads of business development at multi-strategy platforms, the central challenge is no longer whether allocators want multi-strat exposure — it is why they should want yours.

The Problem No One in the Room Wants to Name

Multi-strategy hedge funds are the institutional allocator's preferred vehicle. Goldman Sachs data shows 49% of allocators plan to increase hedge fund exposure in 2026 — a record — with multi-strategy platforms capturing a disproportionate share of that intention. Net inflows hit an estimated $79 billion in 2025. The strategy class just delivered its second consecutive year of double-digit aggregate returns. By every surface metric, the multi-strategy model is winning.

And yet the fundraising conversation has never been harder for the platforms that sit outside the top five.

The reason is structural, and most BD teams are not confronting it directly enough: from the allocator's chair, multi-strategy platforms are converging. The strategies look similar. The pitch decks sound similar. The risk management frameworks are described in near-identical language. The fee structures — increasingly pass-through models that retained an average of 59% of every dollar earned in 2023, up from 46% two years prior — are structurally indistinguishable across platforms.

When everything sounds the same, the allocator defaults to the safest option: the largest platform with the longest track record. For everyone else, the burden of differentiation is the burden of survival.

What Convergence Actually Looks Like

The multi-strategy model was, by design, supposed to produce differentiation. Different pods, different strategies, different return profiles. In practice, the opposite has happened at the industry level.

Multi-manager funds have expanded into overlapping strategy sets — equities stat arb, rates relative value, credit, event-driven, quant macro — producing what Goldman Sachs Asset Management describes as "less differentiated exposures" with "converging strategy mixes that can potentially degrade alpha potential." The platforms are not identical, but from an allocator's perspective, the overlap is significant enough to raise a question that did not exist ten years ago: if I already have exposure to one large multi-strat, what does a second one add?

The data confirms the concern. Multi-strategy funds are showing their highest twelve-month rolling correlation to equities since 2011. For a strategy class whose core value proposition to allocators is uncorrelated returns, this is not a statistical curiosity — it is an existential threat to the pitch. An allocator paying pass-through fees for equity-correlated returns can get equity exposure far more cheaply.

Crowding compounds the problem. In a recent survey, 50% of hedge fund allocators identified crowding as their top concern with multi-manager funds, specifically citing the tendency of platforms to move in tandem during volatile periods. When multiple platforms run similar quant signals, hold similar positions, and hit similar drawdown triggers simultaneously, the diversification that allocators thought they were buying partially evaporates.

The Fee Pressure Dimension

The differentiation problem is amplified by a parallel shift in how allocators evaluate cost.

Between 2022 and September 2024, Citadel's three largest funds charged $12.5 billion in pass-through fees, of which $11 billion was allocated to employee compensation. Point72 states in filings that there is "no limit" on the amount of pass-through expenses it can charge. These numbers, once obscured by strong net returns, are now visible to an allocator base that has become significantly more fee-literate.

The consequence for BD teams is direct. An allocator who is evaluating two multi-strategy platforms with similar gross return profiles, similar strategy compositions, and similar risk management narratives will differentiate on cost. If the platform cannot articulate why its fee structure delivers value that a cheaper alternative does not, the conversation ends — or never starts.

The Man Group CEO's public questioning of the ethics of pass-through fee structures and long lock-ups signalled something more significant than one firm's positioning. It indicated that the fee model itself has become a differentiator. Platforms that can offer fee transparency, alignment mechanisms, or structural advantages on cost are creating BD narratives that their competitors cannot match without changing their own economics.

Why Scale Alone Is No Longer Sufficient

The natural response from the largest platforms is that scale is the differentiator. More pods, more strategies, more diversification, more infrastructure, more data. And for Millennium at $83 billion, Citadel at $65 billion, and Point72 at $45.7 billion, this is partially true — scale creates operational advantages that smaller platforms cannot replicate.

But scale is also producing a new problem: the platforms that returned capital to maintain performance quality are implicitly acknowledging that AUM growth and alpha generation are in tension. Point72 returned $3–5 billion to investors in early 2025 specifically to cap AUM growth and preserve alpha capacity. That is a statement about the limits of scale, not its advantages.

For mid-tier platforms — those managing between $5 billion and $20 billion — the scale argument works in neither direction. They are too large to position as nimble specialists and too small to claim the infrastructure advantages of the top three. This is the zone where differentiation is most critical and most difficult.

It is also where the fundraising competition is most intense. With doors shut at the largest platforms, allocators are actively seeking alternatives among second-tier multi-strategy funds. The capital is available. The question is whether the platform can articulate a reason to receive it that goes beyond "we are a multi-strategy platform with good people and good risk management."

What Genuine Differentiation Looks Like

The platforms that are raising capital effectively in this environment share a common trait: they have identified a specific, defensible dimension on which they are measurably different from their nearest competitors, and they have built their entire allocator narrative around it.

Strategy specialisation within the multi-strat wrapper. The performance data supports this approach. In 2025, tier-two multi-strategy funds averaged 7.7% returns through three quarters, outperforming tier-one firms at 6.6%. Smaller platforms achieved this by leaning into specific strategy niches rather than attempting to replicate the breadth of larger competitors. A platform that runs thirty pods across every strategy category is competing with Millennium. A platform that runs fifteen pods with genuine depth in a specific corner of the market — emerging market credit, volatility arbitrage, systematic commodities — is competing with no one.

Talent quality as a verifiable claim. Allocators have learned to evaluate PM bench depth as a leading indicator of platform health. The platforms that differentiate most effectively on talent are those that can show allocators specific evidence: low voluntary PM turnover relative to peers, a forward pipeline of identified candidates approaching non-compete expiry, and a specific value proposition that explains why senior PMs choose this platform over alternatives. A BD team that can walk an allocator through the platform's talent acquisition process — not just the names on the current roster — is telling a story that most competitors cannot.

Transparency as a competitive weapon. The scope and frequency of investors' operational due diligence demands have escalated substantially. Platforms that offer genuine transparency into pod-level performance attribution, risk decomposition, and strategy allocation are creating an informational advantage that directly addresses the crowding and correlation concerns allocators now raise. The platforms that resist transparency — treating it as a competitive risk rather than a competitive asset — are increasingly finding that opacity is itself a reason for allocators to look elsewhere.

Fee structure innovation. The first platforms to move meaningfully on fee alignment — whether through hurdle rates, clawback mechanisms, or structural caps on pass-through expenses — will create a differentiation moat that is difficult for competitors to cross without restructuring their own economics. The Texas Teachers-led investor coalition calling for performance fees only above cash benchmarks is not a fringe position. It is a preview of where the mainstream allocator conversation is heading.

The BD Team's Role in Solving This

The differentiation crisis is not a marketing problem. It cannot be solved with better pitch decks or more polished LP letters. It requires the BD team to drive an internal conversation that many platforms have not had: what, specifically, does this platform offer that our three nearest competitors do not?

If the honest answer is unclear — or if it amounts to "we are slightly cheaper" or "our people are good" — then the platform has a strategic problem, not a communications one. The BD team is often the first to see this, because they are the ones sitting across from allocators whose questions are becoming sharper and whose patience for generic answers is declining.

The most effective heads of business development in multi-strategy funds today function less like salespeople and more like strategic advisors to their own platforms — feeding allocator intelligence back to the CIO, identifying specific dimensions where the platform can credibly differentiate, and ensuring that the narrative presented to investors reflects something real rather than something polished.

The allocators are not going away. The capital is there. The question — the only question that matters for BD in 2026 — is whether you can give them a reason to choose you that they cannot get from the platform down the road.


Bayes Group works with multi-strategy platforms, systematic funds, global market makers, and proprietary trading firms on senior PM, researcher, Head of Trading, and CIO hiring across the US, APAC, Gulf, and Europe. Talent quality is one of the few genuinely defensible differentiators in multi-strategy fundraising — and it starts with how you acquire PMs. If you want to discuss how a forward hiring approach strengthens your platform narrative, get in touch.

Bayes Group

Ready to discuss a mandate?

We work with a small number of firms at any time.